Home / Dr. Kenneth Rosenfield

Dr. Kenneth Rosenfield

Scientific Advisory Board
Kenneth Rosenfield,

Section Head for Vascular Medicine and Intervention in the Division of Cardiology at Massachusetts General Hospital. He earned a master’s degree in Health Care Delivery Science from Dartmouth College.


A clinical trialist and national principal investigator for several landmark studies, including Levant 2, Superb, ACT 1, and NIH BEST-CLI, he also sat on the Board of Governors of American College of Cardiology, is past-President of the MA ACC Chapter, and is current President of the Society for Cardiovascular Angiography and Interventions (SCAI).


Dr. Rosenfield is a founding member of VIVA, a 501C3 organization, and sits on the board of directors. At Massachusetts General Hospital, Dr. Rosenfield is the Medical director of the PERT (PE Response Teams) Program, which he founded with his colleagues; he also helped found the National PERT Consortium, an organization dedicated to improving management, outcomes, and awareness of pulmonary embolism.

Under-recognized Problem

“ VTE is an under-recognized problem. It strikes something on the order of 800 thousand people a year and  probably as many as a quarter of them are fatal." 


                   -  Dr. Kenneth Rosenfield

                       Thrombolex SAB

Available Now:
Screen Shot 2018-12-15 at 4.46.37 PM.png

The BASHIR™ Endovascular Catheter is a device intended for the localized infusion of physician specified fluids, including thrombolytics, into the peripheral vasculature.

The BASHIR™ N-X Endovascular Catheter is a device intended for the localized infusion of physician specified fluids, into the peripheral vasculature, including the pulmonary arteries.

Need more details? Contact us.

We are here to assist. Contact us by phone, email or via our social media channels.